🚀Na over-correction (Na📈) as THE (only) cause of ODS/CPM: An absurd over-simplification.
Since 1980s, Na📈 has been portrayed as the main cause of CPM (so far as now the terms ODS and CPM are used synonymously).
However, finding the truth (if it exists) is more complicated.
🧵..
1/
📢 The GlomCon Glomerular Disease Fellowship is now accepting applications!
Make sure you don't miss out on the chance to apply for the program, learn from top experts in the field, and engage in interactive workshops with them.
Join the GlomCon family by applying today!
🔗 Learn more: https://t.co/7XIfdsZrzq
@SaynaNorouzi@nephrologista@BetterCallSeeth
#GlomCon #glomconfellowship #GlomerularDisease #nephrology
We are online!
https://t.co/s9npgQsghj
Feel free to submit your articles (section on article types will be released soon) - and reach out to the Editorial Board or me!
Join us on May 30th for GLOMBoston 2026!
🔬This 1-day, live conference focuses on the understanding & management of glomerular disease
💬Learn from expert lectures & interactive case discussions
REGISTER TODAY: https://t.co/KIi73G7rR3
@BetterCallSeeth@AlJurdi@MGBKidneys
Talking complement and C3GN today. Lucky to learn from this amazing panel #glomconhawaii
Drs. Hou, Nester, Isbel, Parikh, Norouzi, Efe, Sperati & Cavanaugh @GlomCon
Time for podocytopathies! Hearing from the anti-Nephrin Queen Dr. Weins #GlomConHawaii@GlomCon
Joining the case discussion panel are Drs. Romagnani, Glassock, Waguespack, Gibson, Rheault & Al Jurdi
A thunderous start to the clinical sessions @ #glomconhawaii
Where else to start but IgA?
Drs. Barratt, Isbel, Radhakrishnan, Zuckerman, Selvaskandan & Norouzi @GlomCon
Kicking off #glomconhawaii with a stellar panel:
Discussion on clinical endpoints in RCTs!
Dr. Nestor @uiowa
Dr. Anders - LMU Munich
Dr. Radhakrishnan @Columbia
Dr. Walsh @McMasterU@GlomCon
Today was graduation day!! 🎓
We were honored to have Dr. @GlassockJ as a speaker for the Fellowship Graduation Ceremony!
Really inspiring and impactful words for all of us!
“If you have the curiosity, the will and the opportunity take it!”
Congratulations to all @GlomCon fellows you are amazing!
As Dr. Glassock said there’s still so many questions and so many opportunitties to enhace knowledge! This is just the beginning!! 🎓🧑🎓👩🎓
Great speech from @SaynaNorouzi and @BetterCallSeeth, the GlomCon family is growing!
#GlomConFellowship #GlomerularDiseases #GlomLove
The Glomerular Disease Fellowship application season is approaching: A year-long program designed for nephrologists seeking advanced training in diagnosing, managing, and researching complex glomerular conditions.
🧠 Expert-led case discussions
📊 Research engagement opportunities
🤝 Global network of peers and mentors
Applications Open: May 19, 2025
Join us and become part of the platform to lead, collaborate, and contribute to the future of glomerular disease care.
Learn more: https://t.co/7XIfdsYTJS
#GlomCon
Defining centers of excellence for glomerular diseases is critical for enhancing patient care. This collaboration with two esteemed partners, the @KidneyFund and the @IGANFoundation is truly significant. It is a proud moment for our nephrology community.
Together, we are indeed stronger. ⭐️🙌🏻
#NephX #Nephrology
HELP!
Unbelievable that @UPS lost out overnight delivery of over 2000 human blood samples on dry ice from our clinical trial!!
Hundreds of patients samples and hundreds of thousands of research $$ down the drain because they can’t find our shipment with perishable human samples 🤬